Back to search

Article

<i> Srsf2 <sup>P95H/+</sup> </i> co-operates with loss of TET2 to promote myeloid bias and initiate a chronic myelomonocytic leukemia like disease in mice

2022-06-21

Abstract excerpt

Recurrent mutations in two pathways - the RNA spliceosome (eg. SRSF2, SF3B1, U2AF1 ) and epigenetic regulators (eg. DNMT3, TET2 ) – contribute to the development of myelodysplastic syndrome (MDS) and related myeloid neoplasms. In chronic myelomonocytic leukemia (CMML), SRSF2 mutations occur in ∼50% of patients and TET2 mutations in ∼60%, representing two of the most frequent mutations in these cancers. Clonal...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e07837c6-8910-54f2-9abe-780e82d4f4d6
DOI
10.1101/2022.06.21.496931
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
<i> Srsf2 <sup>P95H/+</sup> </i> co-operates with loss of TET2 to promote myeloid bias and initiate a chronic myelomonocytic leukemia like disease in miceDOI 10.1101/2022.06.21.496931
Select a neighboring publication to make it the new centre.